Gibson Oncology
Business Services · Florida, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
7772 Fisher Dr, Miami, Florida, 33109, U...Phone Number
(305) 674-7072Website
www.gibsononcology.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Gibson Oncology
Gibson Oncology is focused on developing innovative treatments for brain cancer, particularly glioblastoma, which is notoriously difficult to treat. Their lead program, LMP744, has shown promising pre-clinical results and has received orphan drug designation from the FDA due to its unique properties that allow it to cross the blood-brain barrier. The company is currently collaborating with the NIH on a phase II trial to further explore the efficacy of LMP744. Gibson Oncology aims to provide new hope for patients battling brain cancer through advanced scientific research and development.Explore more
Gibson Oncology Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Gibson Oncology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Gibson Oncology, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Gibson Oncology
Funding: Get notified immidiatlly once Gibson Oncology has new funding data
Check out if Gibson Oncology is spiking on competitors!
Click to see if Gibson Oncology had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Gibson Oncology launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Gibson Oncology has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Gibson Oncology recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Gibson Oncology as Masked Content
Find 3 more new buyers
Compare Similar Companies to Gibson Oncology
Compare insights from companies similar to Gibson Oncology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Gibson Oncology is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Gibson Oncology is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Gibson Oncology.
Gibson Oncology financials insights
Gather financial insights about Gibson Oncology, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Stock/Share Issuance
$250K
Gibson Oncology Tech Stack
A closer look at the technologies used by Gibson Oncology
Gibson Oncology News & Media
Gibson Oncology Expands Its Board of Directors With Accomplished Leadership in Oncology Clinical Development and Corporate Strategy
Gibson Oncology, a privately held Oncology preclinical and clinical development company advancing novel, targeted small molecule compounds that i ...Gibson Oncology Congratulates Dr. Danzhou Yang as Distinguished Professor of Medicinal Chemistry and Molecular Pharmacology at Purdue University
MIAMI--(BUSINESS WIRE)-- #cMyc--Gibson Congratulates one of Gibson's collaborators, Dr. Yang, for her recent accomplishment as Distinguished ProfessorGibson Oncology Expands its Scientific Advisory Board for Novel Oncology cMYC Program
MIAMI--(BUSINESS WIRE)--Dual mechanism, anti-cancer compounds selectively target major oncogene, cMYC, and Topo 1.Gibson Oncology Obtains Exclusive Commercial Rights to Novel Anti-Cancer Drugs That Inhibit the “Undruggable” cMyc Oncogene, a Key Driver for the Majority of Cancers
MIAMI--(BUSINESS WIRE)--Dual mechanism of action, small molecule compounds that inhibit major oncogene, cMyc, and TOPO 1 for treating a multitude of human cancers
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Gibson Oncology
Sign Up For FreeTo access detailed company insights
Gibson Oncology is focused on developing innovative treatments for brain cancer, particularly glioblastoma, which is notoriously difficult to treat. Their lead program, LMP744, has shown promising pre-clinical results and has received orphan drug designation from the FDA due to its unique properties that allow it to cross the blood-brain barrier. T... Read More
